Healthcare provider profile · identity verified

Alejandro Mejia, P.A.

Physician Assistant · BIDDEFORD, ME · NPI 1629266077

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	444	140
Lisinopril	Lisinopril	334	106
Amlodipine Besylate	Amlodipine Besylate	267	83
Metformin Hcl Er	Metformin Hcl	254	77
Levothyroxine Sodium	Levothyroxine Sodium	206	65
Losartan Potassium	Losartan Potassium	192	60
Metoprolol Succinate	Metoprolol Succinate	155	50
Omeprazole	Omeprazole	138	47
Gabapentin	Gabapentin	124	46
Furosemide	Furosemide	122	38
Sertraline Hcl	Sertraline Hcl	111	27
Pantoprazole Sodium	Pantoprazole Sodium	108	33
Alendronate Sodium	Alendronate Sodium	94	30
Jardiance	Empagliflozin	94	23
Albuterol Sulfate Hfa	Albuterol Sulfate	93	35
Metoprolol Tartrate	Metoprolol Tartrate	89	27
Rosuvastatin Calcium	Rosuvastatin Calcium	84	26
Simvastatin	Simvastatin	83	24
Trazodone Hcl	Trazodone Hcl	82	26
Famotidine	Famotidine	81	23
Metformin Hcl	Metformin Hcl	77	20
Duloxetine Hcl	Duloxetine Hcl	67	22
Fluoxetine Hcl	Fluoxetine Hcl	66	17
Hydrochlorothiazide	Hydrochlorothiazide	66	26
Ozempic	Semaglutide	64	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	21
Tamsulosin Hcl	Tamsulosin Hcl	60	21
Trulicity	Dulaglutide	58	15
Eliquis	Apixaban	57	20
Atenolol	Atenolol	55	16
Venlafaxine Hcl Er	Venlafaxine Hcl	52	16
Glipizide	Glipizide	51	12
Glipizide Er	Glipizide	49	19
Bupropion Xl	Bupropion Hcl	48	19
Lovastatin	Lovastatin	48	16
Clopidogrel	Clopidogrel Bisulfate	47	15
Lorazepam	Lorazepam	44	19
Allopurinol	Allopurinol	42	14
Fluticasone Propionate	Fluticasone Propionate	42	15
Potassium Chloride	Potassium Chloride	40	15
Mirtazapine	Mirtazapine	39	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	12
Escitalopram Oxalate	Escitalopram Oxalate	37	13
Ondansetron Odt	Ondansetron	35	19
Pregabalin	Pregabalin	35	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	13
Montelukast Sodium	Montelukast Sodium	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	11
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Prednisone	Prednisone	23	14
Spironolactone	Spironolactone	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	11
Baclofen	Baclofen	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Carvedilol	Carvedilol	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Topiramate	Topiramate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Aripiprazole	Aripiprazole	19	suppressed
Jantoven	Warfarin Sodium	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Risperidone	Risperidone	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Finasteride	Finasteride	13	suppressed
Fluconazole	Fluconazole	13	12
Irbesartan	Irbesartan	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nystatin	Nystatin	13	suppressed
Primidone	Primidone	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Azithromycin	Azithromycin	11	11
Glimepiride	Glimepiride	11	suppressed
Ibu	Ibuprofen	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error